{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "PUBCHEM": "^\\d+$",
      "TAXONOMY": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"
    },
    "path": "anatabine/paris2013.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Nicotine has been shown to modulate inflammation by affecting STAT3 phosphorylation (Chatterjee et al., 2009; Hosur and Loring, 2011) and by opposing NFkB activation (Leite et al., 2010; Zhou et al., 2010)",
      "key": "acba1dc502c48471dd385d55a39bbaae",
      "line": 79,
      "relation": "regulates",
      "source": 2,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Nicotine has been shown to modulate inflammation by affecting STAT3 phosphorylation (Chatterjee et al., 2009; Hosur and Loring, 2011) and by opposing NFkB activation (Leite et al., 2010; Zhou et al., 2010)",
      "key": "d8bb68b4d426d55ddb0d634982081809",
      "line": 80,
      "relation": "association",
      "source": 2,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Nicotine has been shown to modulate inflammation by affecting STAT3 phosphorylation (Chatterjee et al., 2009; Hosur and Loring, 2011) and by opposing NFkB activation (Leite et al., 2010; Zhou et al., 2010)",
      "key": "e22617f727100a93448da3f60cbc72ff",
      "line": 81,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 18
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "An inhibition of TNFa induced STAT3 (Mann–Whitney U=0, Z=-2.121, P=0.034), and p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-2.121, P=0.034) was observed in these cells following the anatabine treatment (Fig. 4) suggesting that anatabine may also mediate its anti-inflammatory activity independently of nicotinic acetylcholine receptor expression",
      "key": "bf25493ff6595ccef27463706b135b88",
      "line": 260,
      "relation": "negativeCorrelation",
      "source": 7,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Nicotine has been shown to modulate inflammation by affecting STAT3 phosphorylation (Chatterjee et al., 2009; Hosur and Loring, 2011) and by opposing NFkB activation (Leite et al., 2010; Zhou et al., 2010)",
      "key": "f038578fa0c385d80e40a12d57f8ab4d",
      "line": 80,
      "relation": "association",
      "source": 16,
      "target": 2
    },
    {
      "key": "b4fdec3e6886d306d2bab20f4a94b773",
      "relation": "hasVariant",
      "source": 15,
      "target": 16
    },
    {
      "key": "95c8739581a4f3a53ac2da935060b155",
      "relation": "partOf",
      "source": 15,
      "target": 8
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Following this 15 mins of stimulation with TNFa, an increased p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-2.309, P=0.021) without a noticeable increase in STAT3 phosphorylation (Mann–Whitney U=7, Z=-0.289, P=0.773) was observed compared to the control conditions (Fig. 1)",
      "key": "9c31290b358d6da42e7405f985bdc809",
      "line": 94,
      "relation": "increases",
      "source": 17,
      "target": 14
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "An increased in both STAT3 (Mann–Whitney U=0, Z=-2.309, P=0.021) and p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-2.309, P=0.021) was observed following 24 h of treatment with TNFa",
      "key": "0dbbe1a5a68e4e402ba6482cfd3aad7c",
      "line": 140,
      "relation": "increases",
      "source": 17,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "TNFa significantly stimulated STAT3 (Mann–Whitney U=0, Z=-2.309, P=0.021) and p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-2.309, P=0.021)",
      "key": "8ff701a8cd92b9bc333af215d8cc5749",
      "line": 246,
      "relation": "increases",
      "source": 17,
      "target": 14
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Following this 15 mins of stimulation with TNFa, an increased p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-2.309, P=0.021) without a noticeable increase in STAT3 phosphorylation (Mann–Whitney U=7, Z=-0.289, P=0.773) was observed compared to the control conditions (Fig. 1)",
      "key": "316f3febe1a4656c21cdea8b304b896e",
      "line": 95,
      "relation": "causesNoChange",
      "source": 17,
      "target": 16
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "An increased in both STAT3 (Mann–Whitney U=0, Z=-2.309, P=0.021) and p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-2.309, P=0.021) was observed following 24 h of treatment with TNFa",
      "key": "ccd6a04397d5f5d60497363793ca84ff",
      "line": 141,
      "relation": "increases",
      "source": 17,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "TNFa significantly stimulated STAT3 (Mann–Whitney U=0, Z=-2.309, P=0.021) and p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-2.309, P=0.021)",
      "key": "59f34c05144c6f1f7b30e96a5234458c",
      "line": 247,
      "relation": "increases",
      "source": 17,
      "target": 16
    },
    {
      "key": "0f97f0e23028811ee21a013fd131684a",
      "relation": "hasVariant",
      "source": 13,
      "target": 14
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "We observed that anatabine inhibits basal STAT3 phosphorylation levels (Mann– Whitney U=0, Z=-2.882, P=0.004) and reduces the induction of p65 NFkB phosphorylation by TNFa (Mann–Whitney U=0, Z=-2.882, P=0.004) within this 15 min time-frame (Fig. 1)",
      "key": "102a7fbc7ad15546557b30c171abe57c",
      "line": 106,
      "relation": "decreases",
      "source": 0,
      "target": 16
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Under these culture conditions, anatabine also inhibited both STAT3 and p65 NFkB phosphorylation induced by TNFa (Fig. 2)",
      "key": "f7116198f7f2f68cca6024021874de03",
      "line": 150,
      "relation": "decreases",
      "source": 0,
      "target": 16
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "A significant inhibition of STAT3 phosphorylation was observed with 600 mg/ml of anatabine (Mann–Whitney U=0, Z=-2.309, P=0.021) and with 800 mg/ml of anatabine (Mann–Whitney U=0, Z=-2.309, P=0.021) and a significant inhibition of p65 NFkB phosphorylation was observed with 600 mg/ml of anatabine (Mann–Whitney U=1.0, Z=-2.021, P=0.043) and with 800 mg/ml of anatabine (Mann–Whitney U=0,Z=-2.309, P=0.021)",
      "key": "5fa115193429ec01f1358a69dfd650bc",
      "line": 165,
      "relation": "decreases",
      "source": 0,
      "target": 16
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "We observed that anatabine significantly suppressed the stimulation of p65 NFkB and STAT3 phosphorylation by LPS in microglia (Fig. 3)",
      "key": "0ba3f879ab1bad1ec9c355a6a6b45eae",
      "line": 198,
      "relation": "decreases",
      "source": 0,
      "target": 16
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Kruskal–Wallis test revealed that doses of anatabine significantly suppressed both LPS induced STAT3 phosphorylation (H=15.658, df=4, P=0.005) and p65 NFkB phosphorylation (H=14.150, df=4, P=0.007) in human microglia",
      "key": "088a9290c3d42c07689b87229f9afac0",
      "line": 210,
      "relation": "decreases",
      "source": 0,
      "target": 16
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "A significant inhibition of STAT3 phosphorylation was observed with 10 mg/ml of anatabine (Mann–Whitney U=1, Z=-2.021, P=0.043), with 100 mg/ml of anatabine (Mann–Whitney U=0, Z=-2.309, P=0.021), with 300 mg/ml of anatabine (Mann–Whitney U=0, Z=-2.309, P=0.021) and with 600 mg/ml of anatabine (Mann–Whitney U=0, Z=-2.309, P=0.021)",
      "key": "7faea36e5cf13ddf3df58b583342c77f",
      "line": 225,
      "relation": "decreases",
      "source": 0,
      "target": 16
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "An inhibition of TNFa induced STAT3 (Mann–Whitney U=0, Z=-2.121, P=0.034), and p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-2.121, P=0.034) was observed in these cells following the anatabine treatment (Fig. 4) suggesting that anatabine may also mediate its anti-inflammatory activity independently of nicotinic acetylcholine receptor expression",
      "key": "e6039286fb35e567c1e2aa1a70397bec",
      "line": 258,
      "relation": "decreases",
      "source": 0,
      "target": 16
    },
    {
      "annotations": {
        "Cell": {
          "mononuclear cell": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Anatabine appears to completely antagonize LPS induced STAT3 (Mann–Whitney U=0, Z=-3.077, P=0.002) and p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-3.077, P=0.002) in human mononuclear cells",
      "key": "1f4b7697dfe532dd1917823ddb4419ac",
      "line": 297,
      "relation": "decreases",
      "source": 0,
      "target": 16
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "We observed that anatabine inhibits basal STAT3 phosphorylation levels (Mann– Whitney U=0, Z=-2.882, P=0.004) and reduces the induction of p65 NFkB phosphorylation by TNFa (Mann–Whitney U=0, Z=-2.882, P=0.004) within this 15 min time-frame (Fig. 1)",
      "key": "ccf309816e762708175d111e37e9f0ba",
      "line": 107,
      "relation": "decreases",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Under these culture conditions, anatabine also inhibited both STAT3 and p65 NFkB phosphorylation induced by TNFa (Fig. 2)",
      "key": "c289e112937ea3ca2dfc32abbe5f43f8",
      "line": 151,
      "relation": "decreases",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "A significant inhibition of STAT3 phosphorylation was observed with 600 mg/ml of anatabine (Mann–Whitney U=0, Z=-2.309, P=0.021) and with 800 mg/ml of anatabine (Mann–Whitney U=0, Z=-2.309, P=0.021) and a significant inhibition of p65 NFkB phosphorylation was observed with 600 mg/ml of anatabine (Mann–Whitney U=1.0, Z=-2.021, P=0.043) and with 800 mg/ml of anatabine (Mann–Whitney U=0,Z=-2.309, P=0.021)",
      "key": "9f42303639cfd08ceb1ddf6f7473aed9",
      "line": 166,
      "relation": "decreases",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "We observed that anatabine significantly suppressed the stimulation of p65 NFkB and STAT3 phosphorylation by LPS in microglia (Fig. 3)",
      "key": "50bb7255a5439a9a4c54a3715e5a3306",
      "line": 200,
      "relation": "decreases",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Kruskal–Wallis test revealed that doses of anatabine significantly suppressed both LPS induced STAT3 phosphorylation (H=15.658, df=4, P=0.005) and p65 NFkB phosphorylation (H=14.150, df=4, P=0.007) in human microglia",
      "key": "6a5884024dfb1e2ef01f494cc2df2ed8",
      "line": 211,
      "relation": "decreases",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Similarly, LPS induced p65 NFkB phosphorylation in microglia was significantly inhibited with 10 mg/ml of anatabine (Mann–Whitney U=0, Z=-2.309, P=0.021), with 100 mg/ml of anatabine (Mann– Whitney U=0, Z=-2.309, P=0.021), with 300 mg/ml of anatabine (Mann–Whitney U=0, Z=-2.309, P=0.021)",
      "key": "1cc928145b6af9f91f02166d6f63837c",
      "line": 238,
      "relation": "decreases",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "An inhibition of TNFa induced STAT3 (Mann–Whitney U=0, Z=-2.121, P=0.034), and p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-2.121, P=0.034) was observed in these cells following the anatabine treatment (Fig. 4) suggesting that anatabine may also mediate its anti-inflammatory activity independently of nicotinic acetylcholine receptor expression",
      "key": "b38e878370d15b808188177bd492cb54",
      "line": 259,
      "relation": "decreases",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "Cell": {
          "mononuclear cell": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Anatabine appears to completely antagonize LPS induced STAT3 (Mann–Whitney U=0, Z=-3.077, P=0.002) and p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-3.077, P=0.002) in human mononuclear cells",
      "key": "6a38eb9c5d7e25ad15455d4c5da0b3c4",
      "line": 296,
      "relation": "decreases",
      "source": 0,
      "target": 14
    },
    {
      "annotations": {
        "CellLine": {
          "HEK293": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "An inhibition of TNFa induced STAT3 (Mann–Whitney U=0, Z=-2.121, P=0.034), and p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-2.121, P=0.034) was observed in these cells following the anatabine treatment (Fig. 4) suggesting that anatabine may also mediate its anti-inflammatory activity independently of nicotinic acetylcholine receptor expression",
      "key": "1562d24b27ddf265f53cc841ede5cf4e",
      "line": 260,
      "relation": "negativeCorrelation",
      "source": 0,
      "target": 7
    },
    {
      "key": "d48912f7db088e598f177896b3524522",
      "relation": "partOf",
      "source": 0,
      "target": 11
    },
    {
      "key": "82fc5e440a1d055aaf574366d7182f9b",
      "relation": "partOf",
      "source": 0,
      "target": 10
    },
    {
      "key": "11e3921afbaf07f6dc2c69757ae9a1a2",
      "relation": "partOf",
      "source": 0,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Kidney": true,
          "Spleen": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Western-blot experiments revealed that LPS significantly stimulated of STAT3 phosphorylation in the spleen (Mann–Whitney U=0, Z=-2.309, P=0.021) (Fig. 8) and kidney (Mann–Whitney U=0, Z=-2.882, P=0.004) (data not shown) whereas anatabine significantly inhibited STAT3 phosphorylation in the spleen (Mann–Whitney U=1, Z=-2.021, P=0.043) and kidney (Mann– Whitney U=5, Z=-2.082, P=0.037) (data not shown)",
      "key": "62ce287e02e591480677d5c95bf9d591",
      "line": 385,
      "relation": "decreases",
      "source": 0,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "A significant elevation of STAT3 phosphorylation was detected in the brain of Tg APPsw compared to their control littermates (Mann–Whitney U=1, Z=-3.767, p<0.001) and a significant reduction in STAT3 phosphorylation (Mann–Whitney U=8, Z=-2.066, p=0.039) was observed in the brain of Tg APPsw treated with anatabine compared to untreated Tg APPsw littermates (Fig. 10).",
      "key": "e4db1d9cd65fbf9a85d69698360e1214",
      "line": 425,
      "relation": "decreases",
      "source": 0,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Following 90 days of treatment with anatabine, a significant reduction in brain TNF-a (Mann–Whitney U=6, Z=-2.146, p=0.032) and in IL-6 (Mann–Whitney U=0, Z=-2.887, p=0.004) was observed in Tg APPsw mice compared to Tg APPsw that received regular drinking water (Fig. 9)",
      "key": "1e3ea5beb9afdb28d5bf2410ce95d100",
      "line": 410,
      "relation": "decreases",
      "source": 0,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Following 90 days of treatment with anatabine, a significant reduction in brain TNF-a (Mann–Whitney U=6, Z=-2.146, p=0.032) and in IL-6 (Mann–Whitney U=0, Z=-2.887, p=0.004) was observed in Tg APPsw mice compared to Tg APPsw that received regular drinking water (Fig. 9)",
      "key": "508879ad77c8bc80065504125ce15c5c",
      "line": 411,
      "relation": "decreases",
      "source": 0,
      "target": 20
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "As a positive control, we used stattic, a known inhibitor of STAT3 dimerization and phosphorylation",
      "key": "f1875ec397ab99ec61d57fc24f32ddd5",
      "line": 115,
      "relation": "decreases",
      "source": 3,
      "target": 16
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "We found that stattic inhibited STAT3 phosphorylation (Mann–Whitney U=0, Z=-2.324, P=0.02) and also suppressed p65 NFkB phosphorylation (Mann–Whitney U¼0, Z¼\u00022.324, P¼0.02) mimicking the effect of anatabine in SHSY5Y cells (Fig. 1)",
      "key": "4f7b748ed06e2f51e6f3b18573e6c56b",
      "line": 127,
      "relation": "decreases",
      "source": 3,
      "target": 16
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "As a positive control, we used stattic, a known inhibitor of STAT3 dimerization and phosphorylation",
      "key": "261c1c94d8243e3e3732a83e6ed3b7a5",
      "line": 116,
      "relation": "decreases",
      "source": 3,
      "target": 8
    },
    {
      "annotations": {
        "CellLine": {
          "SH-SY5Y": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "We found that stattic inhibited STAT3 phosphorylation (Mann–Whitney U=0, Z=-2.324, P=0.02) and also suppressed p65 NFkB phosphorylation (Mann–Whitney U¼0, Z¼\u00022.324, P¼0.02) mimicking the effect of anatabine in SHSY5Y cells (Fig. 1)",
      "key": "d8a194a96336333ce9ed627a640352cd",
      "line": 128,
      "relation": "decreases",
      "source": 3,
      "target": 14
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "We next tested the impact of anatabine on STAT3 and p65 NFkB phosphorylation induced by a 24 h treatment with LPS on human microglial cells, a cell type known to express alpha7-nicotinic acetylcholine receptor subtype (Suzuki et al., 2006)",
      "key": "a3d44d05aa62b2c56d108caad84eec37",
      "line": 177,
      "relation": "increases",
      "source": 6,
      "target": 4
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "An increased STAT3 (Mann–Whitney U=0, Z=-2.309, P=0.021) and p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-2.309, p=0.021) was observed in LPS treated microglia (Fig. 3)",
      "key": "dfc6d5fd1a7ba1299e5881d9ac871fa7",
      "line": 188,
      "relation": "increases",
      "source": 1,
      "target": 16
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "We observed that anatabine significantly suppressed the stimulation of p65 NFkB and STAT3 phosphorylation by LPS in microglia (Fig. 3)",
      "key": "8b14b567d1c942b1a103c25f6deef957",
      "line": 197,
      "relation": "increases",
      "source": 1,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Following a 24 h incubation with LPS, a significant stimulation of STAT3 (Mann– Whitney U=0, Z=-2.882, P=0.004) and p65 NFkB phosphorylation was observed (Mann–Whitney U=1, Z=-2.722, P=0.006)",
      "key": "2e53a69ddeac6c6da62b98f4fc90c63e",
      "line": 287,
      "relation": "increases",
      "source": 1,
      "target": 16
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "An increased STAT3 (Mann–Whitney U=0, Z=-2.309, P=0.021) and p65 NFkB phosphorylation (Mann–Whitney U=0, Z=-2.309, p=0.021) was observed in LPS treated microglia (Fig. 3)",
      "key": "016d09ac89deb51e43257cc9dc90e679",
      "line": 189,
      "relation": "increases",
      "source": 1,
      "target": 14
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "We observed that anatabine significantly suppressed the stimulation of p65 NFkB and STAT3 phosphorylation by LPS in microglia (Fig. 3)",
      "key": "ba4b1ed3d622f0b82d8aefe705bbf6f8",
      "line": 199,
      "relation": "increases",
      "source": 1,
      "target": 14
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Similarly, LPS induced p65 NFkB phosphorylation in microglia was significantly inhibited with 10 mg/ml of anatabine (Mann–Whitney U=0, Z=-2.309, P=0.021), with 100 mg/ml of anatabine (Mann– Whitney U=0, Z=-2.309, P=0.021), with 300 mg/ml of anatabine (Mann–Whitney U=0, Z=-2.309, P=0.021)",
      "key": "0b115e80aa674442b8f37cfd9534eeb4",
      "line": 237,
      "relation": "increases",
      "source": 1,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Following a 24 h incubation with LPS, a significant stimulation of STAT3 (Mann– Whitney U=0, Z=-2.882, P=0.004) and p65 NFkB phosphorylation was observed (Mann–Whitney U=1, Z=-2.722, P=0.006)",
      "key": "8f60176d6ad4b2ea44833f498ef71f7c",
      "line": 286,
      "relation": "increases",
      "source": 1,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Anatabine at 200 mg/ ml significantly lowered LPS induced IL-1b levels in whole blood (Mann–Whitney U=0.0, Z=-2.3, P=0.02)",
      "key": "4dfa8c16044168e380ec95ae48ec5243",
      "line": 269,
      "relation": "increases",
      "source": 1,
      "target": 12
    },
    {
      "key": "8b4f0af8d5d4f7b8dbcfed702e8fa89d",
      "relation": "partOf",
      "source": 1,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Plasma": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Our results showed that intraperitoneal injection of LPS (1 mg/kg) caused a significant elevation of plasma IL-1b (Mann–Whitney U=3, Z=-2.988, P=0.003), IL-6 (Mann–Whitney U=0, Z=-3.366, P=0.001) and TNFa (Mann– Whitney U=0, Z=-3.508, P<0.001) 4 h after the LPS challenge whereas in mice co-treated with an intraperitoneal injection of anatabine (2 mg/kg) and LPS, a significant reduction in plasma IL-1b (Mann–Whitney U=7, Z=-2.645, P=0.008) and TNFa (Mann–Whitney U=4, Z=-2.941, P=0.003) levels was observed (Fig. 6)",
      "key": "e0ee04c5a7df39914dcce075f9038a6f",
      "line": 311,
      "relation": "increases",
      "source": 1,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "An elevation of IL-6 (Mann–Whitney U=0, Z=-3.487, P<0.001), IL1b (Mann– Whitney U=0, Z=-3.24, P=0.001) and TNFa (Mann–Whitney U=0, Z=-3.361, P=0.001) was observed in the spleen of LPS challenged mice (Fig. 7)",
      "key": "040232f438a150ca5c5a105abf2e646b",
      "line": 333,
      "relation": "increases",
      "source": 1,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Kidney": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Similarly, IL-1b (Mann–Whitney U=0, Z=-3.098, P=0.002), IL-6 (Mann–Whitney U=0, Z=-3.363, P<0.001) and TNF-a levels (Mann–Whitney U=0, Z=-3.361, P=0.001) were elevated in the kidney following the LPS challenge (data not shown)",
      "key": "9269c3db3697cc3483f095a4d79a7ab6",
      "line": 357,
      "relation": "increases",
      "source": 1,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Plasma": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Our results showed that intraperitoneal injection of LPS (1 mg/kg) caused a significant elevation of plasma IL-1b (Mann–Whitney U=3, Z=-2.988, P=0.003), IL-6 (Mann–Whitney U=0, Z=-3.366, P=0.001) and TNFa (Mann– Whitney U=0, Z=-3.508, P<0.001) 4 h after the LPS challenge whereas in mice co-treated with an intraperitoneal injection of anatabine (2 mg/kg) and LPS, a significant reduction in plasma IL-1b (Mann–Whitney U=7, Z=-2.645, P=0.008) and TNFa (Mann–Whitney U=4, Z=-2.941, P=0.003) levels was observed (Fig. 6)",
      "key": "501f6f4bca13d932e386b858a9fbc8ac",
      "line": 312,
      "relation": "increases",
      "source": 1,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "An elevation of IL-6 (Mann–Whitney U=0, Z=-3.487, P<0.001), IL1b (Mann– Whitney U=0, Z=-3.24, P=0.001) and TNFa (Mann–Whitney U=0, Z=-3.361, P=0.001) was observed in the spleen of LPS challenged mice (Fig. 7)",
      "key": "386669c37d1faf6dbb391fc5f72f8eb0",
      "line": 334,
      "relation": "increases",
      "source": 1,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Kidney": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Similarly, IL-1b (Mann–Whitney U=0, Z=-3.098, P=0.002), IL-6 (Mann–Whitney U=0, Z=-3.363, P<0.001) and TNF-a levels (Mann–Whitney U=0, Z=-3.361, P=0.001) were elevated in the kidney following the LPS challenge (data not shown)",
      "key": "4bacc2f1cd4fb3a8d6c2bebdb21236b0",
      "line": 358,
      "relation": "increases",
      "source": 1,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Plasma": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Our results showed that intraperitoneal injection of LPS (1 mg/kg) caused a significant elevation of plasma IL-1b (Mann–Whitney U=3, Z=-2.988, P=0.003), IL-6 (Mann–Whitney U=0, Z=-3.366, P=0.001) and TNFa (Mann– Whitney U=0, Z=-3.508, P<0.001) 4 h after the LPS challenge whereas in mice co-treated with an intraperitoneal injection of anatabine (2 mg/kg) and LPS, a significant reduction in plasma IL-1b (Mann–Whitney U=7, Z=-2.645, P=0.008) and TNFa (Mann–Whitney U=4, Z=-2.941, P=0.003) levels was observed (Fig. 6)",
      "key": "d027a754e5036f67ec4e7ef7aa22a879",
      "line": 313,
      "relation": "increases",
      "source": 1,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "An elevation of IL-6 (Mann–Whitney U=0, Z=-3.487, P<0.001), IL1b (Mann– Whitney U=0, Z=-3.24, P=0.001) and TNFa (Mann–Whitney U=0, Z=-3.361, P=0.001) was observed in the spleen of LPS challenged mice (Fig. 7)",
      "key": "84d07a2b474caec5b84ae5d228a444af",
      "line": 335,
      "relation": "increases",
      "source": 1,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Kidney": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Similarly, IL-1b (Mann–Whitney U=0, Z=-3.098, P=0.002), IL-6 (Mann–Whitney U=0, Z=-3.363, P<0.001) and TNF-a levels (Mann–Whitney U=0, Z=-3.361, P=0.001) were elevated in the kidney following the LPS challenge (data not shown)",
      "key": "f5b6bc22ddfe3e60887971550c9cddec",
      "line": 359,
      "relation": "increases",
      "source": 1,
      "target": 23
    },
    {
      "key": "54a3fe86b5bec7719ea38dfd4aa2d60b",
      "relation": "partOf",
      "source": 1,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Kidney": true,
          "Spleen": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Western-blot experiments revealed that LPS significantly stimulated of STAT3 phosphorylation in the spleen (Mann–Whitney U=0, Z=-2.309, P=0.021) (Fig. 8) and kidney (Mann–Whitney U=0, Z=-2.882, P=0.004) (data not shown) whereas anatabine significantly inhibited STAT3 phosphorylation in the spleen (Mann–Whitney U=1, Z=-2.021, P=0.043) and kidney (Mann– Whitney U=5, Z=-2.082, P=0.037) (data not shown)",
      "key": "21bb6062e4117c59cfbd0f4f46b7fbd3",
      "line": 384,
      "relation": "increases",
      "source": 1,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Anatabine at 200 mg/ ml significantly lowered LPS induced IL-1b levels in whole blood (Mann–Whitney U=0.0, Z=-2.3, P=0.02)",
      "key": "95edfd9240edd0c9a525cbde1879ba3f",
      "line": 268,
      "relation": "decreases",
      "source": 11,
      "target": 12
    },
    {
      "key": "0df55d63796ce4a7de119cddec4667d0",
      "relation": "partOf",
      "source": 5,
      "target": 11
    },
    {
      "key": "d8e35d67176df90bea11a508285219e0",
      "relation": "partOf",
      "source": 5,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Higher doses of anatabine resulted in a complete suppression of IL-1b levels in LPS challenged human blood (Mann–Whitney U=0.0, Z=-2.5, P=0.01)",
      "key": "76bf744e9aef8ad88856d9fefdb7a248",
      "line": 277,
      "relation": "decreases",
      "source": 10,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Plasma": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Our results showed that intraperitoneal injection of LPS (1 mg/kg) caused a significant elevation of plasma IL-1b (Mann–Whitney U=3, Z=-2.988, P=0.003), IL-6 (Mann–Whitney U=0, Z=-3.366, P=0.001) and TNFa (Mann– Whitney U=0, Z=-3.508, P<0.001) 4 h after the LPS challenge whereas in mice co-treated with an intraperitoneal injection of anatabine (2 mg/kg) and LPS, a significant reduction in plasma IL-1b (Mann–Whitney U=7, Z=-2.645, P=0.008) and TNFa (Mann–Whitney U=4, Z=-2.941, P=0.003) levels was observed (Fig. 6)",
      "key": "9a356c5fec9b72c2c5b9ed551c7fa357",
      "line": 314,
      "relation": "decreases",
      "source": 9,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Anatabine significantly inhibited LPS induced IL-6 (Mann–Whitney U=4, Z=-3.303, P=0.001), TNF-a (Mann–Whitney U=0, Z=-3.361, P=0.001) and IL-1b levels in the spleen (Mann–Whitney U=9, Z=-1.981, P=0.048) (Fig. 7)",
      "key": "a677ef73532be0c88133abccb4781736",
      "line": 345,
      "relation": "decreases",
      "source": 9,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Plasma": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Our results showed that intraperitoneal injection of LPS (1 mg/kg) caused a significant elevation of plasma IL-1b (Mann–Whitney U=3, Z=-2.988, P=0.003), IL-6 (Mann–Whitney U=0, Z=-3.366, P=0.001) and TNFa (Mann– Whitney U=0, Z=-3.508, P<0.001) 4 h after the LPS challenge whereas in mice co-treated with an intraperitoneal injection of anatabine (2 mg/kg) and LPS, a significant reduction in plasma IL-1b (Mann–Whitney U=7, Z=-2.645, P=0.008) and TNFa (Mann–Whitney U=4, Z=-2.941, P=0.003) levels was observed (Fig. 6)",
      "key": "9719fadfab4c70cbb84ccaaee58f4750",
      "line": 315,
      "relation": "decreases",
      "source": 9,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Anatabine significantly inhibited LPS induced IL-6 (Mann–Whitney U=4, Z=-3.303, P=0.001), TNF-a (Mann–Whitney U=0, Z=-3.361, P=0.001) and IL-1b levels in the spleen (Mann–Whitney U=9, Z=-1.981, P=0.048) (Fig. 7)",
      "key": "6d98aa4a31712c1b79731a8b6b6d35b4",
      "line": 347,
      "relation": "decreases",
      "source": 9,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Kidney": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "A significant reduction in TNF-a (Mann–Whitney U=12, Z=-2.309, P=0.021) but no significant reduction in IL-6 levels (Mann–Whitney U=25, Z=-1.223, P=0.221) or IL-1b (Mann–Whitney U=8, Z=-1.857,P=0.063) were observed in the kidney of LPS and anatabine cotreated animals (data not shown)",
      "key": "50c3332a9fd071d0ec26dd699db935b2",
      "line": 371,
      "relation": "decreases",
      "source": 9,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Plasma": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Plasma IL-6 levels show a trend for a reduction but were not significantly affected (Mann–Whitney U=19, Z=-1.368, P=0.171) by the anatabine treatment (Fig. 6)",
      "key": "2318c34f0a82345219575142fcd58b95",
      "line": 324,
      "relation": "decreases",
      "source": 9,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Spleen": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "Anatabine significantly inhibited LPS induced IL-6 (Mann–Whitney U=4, Z=-3.303, P=0.001), TNF-a (Mann–Whitney U=0, Z=-3.361, P=0.001) and IL-1b levels in the spleen (Mann–Whitney U=9, Z=-1.981, P=0.048) (Fig. 7)",
      "key": "744d1404f80128b59c9257205083a41f",
      "line": 346,
      "relation": "decreases",
      "source": 9,
      "target": 20
    },
    {
      "key": "0c7463a4cb99489ca2bc64dfb7e69050",
      "relation": "hasVariant",
      "source": 21,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "An elevation of brain IL-6 (Mann–Whitney U=0, Z=-3, p=0.003) and TNF-a (Mann–Whitney U=0, Z=-2.887, p=0.004) was observed in Tg APPsw mice compared to their wild-type littermates (Fig. 9)",
      "key": "a43d0999415752f1ba900e38d6db6f00",
      "line": 396,
      "relation": "increases",
      "source": 24,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "An elevation of brain IL-6 (Mann–Whitney U=0, Z=-3, p=0.003) and TNF-a (Mann–Whitney U=0, Z=-2.887, p=0.004) was observed in Tg APPsw mice compared to their wild-type littermates (Fig. 9)",
      "key": "8fda41a41cf89ce3eaa364cc55a3600d",
      "line": 397,
      "relation": "increases",
      "source": 24,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Abdullah L",
          "Ait-Ghezala G",
          "Bachmeier C",
          "Beaulieu-Abdelahad D",
          "Crawford F",
          "Mullan M",
          "Paris D",
          "Reed J",
          "Verma M"
        ],
        "date": "2013-01-05",
        "db": "PubMed",
        "db_id": "23178521",
        "db_name": "Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation.",
        "first": "Paris D",
        "journal": "European journal of pharmacology",
        "last": "Mullan M",
        "pages": "145-53",
        "volume": "698"
      },
      "evidence": "A significant elevation of STAT3 phosphorylation was detected in the brain of Tg APPsw compared to their control littermates (Mann–Whitney U=1, Z=-3.767, p<0.001) and a significant reduction in STAT3 phosphorylation (Mann–Whitney U=8, Z=-2.066, p=0.039) was observed in the brain of Tg APPsw treated with anatabine compared to untreated Tg APPsw littermates (Fig. 10).",
      "key": "363f43368f2556c09916aa93e5a8754c",
      "line": 424,
      "relation": "increases",
      "source": 24,
      "target": 22
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:Anatabine)",
      "concept": {
        "name": "Anatabine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9e5ab9569cca155e199162d8c20415b4"
    },
    {
      "bel": "a(CHEBI:lipopolysaccharide)",
      "concept": {
        "name": "lipopolysaccharide",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9d74ac839ff5ff882ee29395de5ecb86"
    },
    {
      "bel": "a(CHEBI:nicotine)",
      "concept": {
        "name": "nicotine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "44ed555f78bacda2933ddef1d4280ce9"
    },
    {
      "bel": "a(CHEBI:stattic)",
      "concept": {
        "name": "stattic",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "7193579db290b924e5954c3985f47aba"
    },
    {
      "bel": "a(MESH:\"alpha7 Nicotinic Acetylcholine Receptor\")",
      "concept": {
        "name": "alpha7 Nicotinic Acetylcholine Receptor",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "58b5f9ca1e8fc58bac5d0b7c4002e2bd"
    },
    {
      "bel": "a(MESH:Blood)",
      "concept": {
        "name": "Blood",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "606f9b44b83854ab41b1a7d773a72f8c"
    },
    {
      "bel": "a(MESH:Microglia)",
      "concept": {
        "name": "Microglia",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "4ef490b325b2b1e33e41b4e22e1bd8c6"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "concept": {
        "name": "inflammatory response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "abd32f6c5cca606061975532840db260"
    },
    {
      "bel": "complex(p(HGNC:STAT3), p(HGNC:STAT3))",
      "function": "Complex",
      "id": "0d04fc3f3d77d560649c3ce43a29220e",
      "members": [
        {
          "bel": "p(HGNC:STAT3)",
          "concept": {
            "name": "STAT3",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "9523cd88bdb7daf4a0aaf38eb43fbe28"
        },
        {
          "bel": "p(HGNC:STAT3)",
          "concept": {
            "name": "STAT3",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "9523cd88bdb7daf4a0aaf38eb43fbe28"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:Anatabine), a(CHEBI:lipopolysaccharide))",
      "function": "Composite",
      "id": "c394534478dc0e915dd4a652fb2a9928",
      "members": [
        {
          "bel": "a(CHEBI:Anatabine)",
          "concept": {
            "name": "Anatabine",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "9e5ab9569cca155e199162d8c20415b4"
        },
        {
          "bel": "a(CHEBI:lipopolysaccharide)",
          "concept": {
            "name": "lipopolysaccharide",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "9d74ac839ff5ff882ee29395de5ecb86"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:Anatabine), a(CHEBI:lipopolysaccharide), a(MESH:Blood))",
      "function": "Composite",
      "id": "cfaf20149242bd5cdd538b31dfbf5fea",
      "members": [
        {
          "bel": "a(CHEBI:Anatabine)",
          "concept": {
            "name": "Anatabine",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "9e5ab9569cca155e199162d8c20415b4"
        },
        {
          "bel": "a(CHEBI:lipopolysaccharide)",
          "concept": {
            "name": "lipopolysaccharide",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "9d74ac839ff5ff882ee29395de5ecb86"
        },
        {
          "bel": "a(MESH:Blood)",
          "concept": {
            "name": "Blood",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "606f9b44b83854ab41b1a7d773a72f8c"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:Anatabine), a(MESH:Blood))",
      "function": "Composite",
      "id": "04fc91ed223c0fe201b21f5fda903bcf",
      "members": [
        {
          "bel": "a(CHEBI:Anatabine)",
          "concept": {
            "name": "Anatabine",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "9e5ab9569cca155e199162d8c20415b4"
        },
        {
          "bel": "a(MESH:Blood)",
          "concept": {
            "name": "Blood",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "606f9b44b83854ab41b1a7d773a72f8c"
        }
      ]
    },
    {
      "bel": "p(HGNC:IL1B)",
      "concept": {
        "name": "IL1B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cca08112d9fcf1a31015f1dbfc30b04c"
    },
    {
      "bel": "p(HGNC:RELA)",
      "concept": {
        "name": "RELA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "64cb49613db164980ff43274b6c270cf"
    },
    {
      "bel": "p(HGNC:RELA, pmod(Ph))",
      "concept": {
        "name": "RELA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cf5af122438c46b3b2db16bb924ef9ed",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:STAT3)",
      "concept": {
        "name": "STAT3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9523cd88bdb7daf4a0aaf38eb43fbe28"
    },
    {
      "bel": "p(HGNC:STAT3, pmod(Ph))",
      "concept": {
        "name": "STAT3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b459f1fb99346abf4c46d7a952b1cc1f",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:TNF)",
      "concept": {
        "name": "TNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "fdc1c1f5a73c3c992b6eb71ce9b6908e"
    },
    {
      "bel": "p(MESH:\"NF-kappa B\")",
      "concept": {
        "name": "NF-kappa B",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "9228a14f7f8871cda32bcfe688ed5689"
    },
    {
      "bel": "p(MGI:Il1b)",
      "concept": {
        "name": "Il1b",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "d3c8a0f2556b008ddf2008821247671a"
    },
    {
      "bel": "p(MGI:Il6)",
      "concept": {
        "name": "Il6",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "461076a43183c4f1e4e9b4954be313fe"
    },
    {
      "bel": "p(MGI:Stat3)",
      "concept": {
        "name": "Stat3",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "79991a875fd41c45120dc943a15ccb29"
    },
    {
      "bel": "p(MGI:Stat3, pmod(Ph))",
      "concept": {
        "name": "Stat3",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "c89a99f3f3bf8bb26cb28a7d2fe34cb9",
      "variants": [
        {
          "concept": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(MGI:Tnf)",
      "concept": {
        "name": "Tnf",
        "namespace": "MGI"
      },
      "function": "Protein",
      "id": "cd5c5c12b7855d35a3e18c5ee16eb074"
    },
    {
      "bel": "path(MESH:\"Alzheimer Disease\")",
      "concept": {
        "name": "Alzheimer Disease",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2ae8307f5fd59056199369691367cc96"
    }
  ]
}